Marksans Pharma Ltd. — Call Transcript 2023

Feb 7, 2023

·t· Marksans Pharma Ltd.

BSE Limited Corporate Relation Department PhirozeJeejeeboi Towers, Dalal Street, Mumbai - 400001. Scrip Code: 524404

National Stock Exchange oflndia Limited Listing Department Exchange Plaza, C-1, Block-G, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051. Symbol: MARKSANS

Further to our letter dated February 4, 2023, please be informed that Earnings Conference Call has been preponed to 3:30 P.M. (1ST) (instead of5:00 P.M.) on Tuesday, February 14,2023.

Yours faithfully, For Marksans Pharma Limited

HARSHAVA Digitally signed by HARSHAVARDHAN RDHAN PANIGRAHI Date: 2023.02.07 PANIGRAHI 16:59:10 +05'30' Harshavardhan Panigrahi Company Secretary

www.marksanspharma.com

==> picture [223 x 67] intentionally omitted <==

SYSTEMATIX INSTITUTIONAL EQUITIES

Invites you to participate in

3QFY23 Results Conference Call of

==> picture [65 x 65] intentionally omitted <==

Marksans Pharma Ltd.

On Tuesday, 14[th] February 2023 at 03.30 PM (IST)

The management will be represented by

Mr. Mark Saldanha Mr. Jitendra Sharma Founder, Chairman, and Managing Director Chief Financial Officer

Marksans Pharma is a generic drug formulation manufacturing company focused on the Private label OTC category products in regulated markets like the US and UK. The company has delivered 12% compounded net earnings growth over the last 10 years and continues to generate healthy ROCE despite the inflationary environment and pricing pressures in regulated markets.

 Dial-in-number

Please join us on Zoom Meeting = https://us06web.zoom.us/j/84436356705?pwd aUxuZ25vaE12TFBUNlpyYnFaeStFZz09 Meeting ID 844 3635 6705 Passcode 139708

For more information, please contact:

Vishal Manchanda Pearl Pillay Contact No: +91 97374 37148 Contact No: +91 91674 66762 vishalmanchanda@systematixgroup.in pearlpillay@systematixgroup.in